EPS Actual
—
Revenue
—
EPS Surprise
—
Status
Pending
Investor Toolbox
Listen to Call
Recording not yet available.
Read Transcript
Transcript not yet available.
View Infographic
Infographic not yet available.
BRKR Coverage
Event
Bruker Corp (BRKR) Bruker Introduces iNTApharma™, a Label‑Free Platform for Nanoparticle Characterization in mRNA Drug and Gene Therapy Development and QC
Feb 9, 2026
Transcript
Bruker Corp (BRKR) Q2 2025 Earnings Call Transcript
Jan 22, 2026
Transcript
Bruker Corp (BRKR) Q3 2025 Earnings Call Transcript
Jan 22, 2026